SCHEMBL27384346

SCHEMBL27384346

CC(C)c1cc2[nH]c(CNC(=O)N3CCC3C)cc2cc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EIF4A3 P38919 1/20 0.45
▸ RAB9A P51151 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ METTL3 Q86U44 3/20 0.35
▸ METTL14 Q9HCE5 3/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ CHRM4 P08173 2/20 0.32
▸ HRH3 Q9Y5N1 1/20 0.31
▸ AADAT Q8N5Z0 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ CHRM1 P11229 2/20 0.31
▸ CHRM5 P08912 1/20 0.31
▸ CHRM3 P20309 1/20 0.31
▸ KIT P10721 2/20 0.31
▸ CHRM2 P08172 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ TRPV1 Q8NER1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384352 0.83 EIF4A3 (0.49) EIF4A3RAB9ANPC1METTL3METTL14
SCHEMBL27384648 0.83 EIF4A3 (0.48) EIF4A3RAB9ANPC1METTL3METTL14
SCHEMBL27384655 0.83 EIF4A3 (0.48) EIF4A3RAB9ANPC1METTL3METTL14
SCHEMBL27384340 0.82 EIF4A3 (0.47) EIF4A3RAB9ANPC1METTL3METTL14
SCHEMBL27384451 0.82 AADAT (0.38) RAB9AMAPK1SMN1; SMN2HRH3AADAT
SCHEMBL27384348 0.81 EIF4A3 (0.46) EIF4A3RAB9ANPC1METTL3METTL14
SCHEMBL27383728 0.81 RAB9A (0.53) EIF4A3RAB9ANPC1METTL3METTL14
SCHEMBL27384455 0.80 RAB9A (0.41) RAB9ANPC1METTL3METTL14SMN1; SMN2
SCHEMBL27382678 0.79 EIF4A3 (0.56) EIF4A3RAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL27382556 0.78 EIF4A3 (0.54) EIF4A3RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081748-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback